Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOld Mutual Lim. Regulatory News (OMU)

Share Price Information for Old Mutual Lim. (OMU)

Share Price is delayed by 15 minutes
Get Live Data
58.00    1.20 (2.11%)
Bid:
57.80
Ask:
59.20
Spread: 1.40 (2.422%)
Market Cap: £2.33b
OMU Live PriceLast checked at - London Stock Exchange

Intraday Old Mutual Lim. Share Chart

Form 8.3 - Mediclinic International plc

12 Oct 2022 13:00

RNS Number : 6735C
Old Mutual Limited
12 October 2022
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

 

 Old Mutual Limited (and subsidiaries)

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Mediclinic International plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

11/ 10 / 2022

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

 

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

50p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

8,785,409

1.19%

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

8,785,409

 

 

1.19%

 

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

Ordinary

Purchase

3 219

99.03

 

 (b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

 

No

 

 

Date of disclosure:

12 October 2022

Contact name:

Rasheeqah Ismail

Telephone number:

+27(0)82 0690 377

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETFFFFFEEESEFS
Date   Source Headline
11th Apr 20222:00 pmRNSDealings in securities on behalf of ESIS
31st Mar 20229:00 amRNSBEE certificate and annual compliance report
25th Mar 20227:30 amRNSAcquisition of securities by BlackRock Inc
24th Mar 202212:30 pmRNSDisposal of Securities by clients of Allan Gray
24th Mar 20227:00 amRNSNo change statement
22nd Mar 20228:30 amRNSFinalisation & Dividend Currency Equivalents
15th Mar 20227:00 amRNSReviewed annual results and dividend declaration
23rd Feb 20227:00 amRNSTrading Statement
13th Dec 20213:00 pmRNSSecurities dealing on behalf of a share trust
10th Dec 20212:30 pmRNSDealings in securities on behalf of LTIP
10th Dec 20212:30 pmRNSDealings in Securities on behalf of ESOP
3rd Dec 202110:00 amRNSDealings in securities on behalf of Share Trusts
23rd Nov 20217:00 amRNSVoluntary Operating Update
19th Nov 202111:00 amRNSDealings in securities on behalf of share trusts
17th Nov 202112:00 pmRNSSecurities dealing on behalf of share trusts
12th Nov 20212:30 pmRNSSecurities dealing on behalf of Share Trusts
4th Nov 20218:00 amRNSCash proceeds - fractional entitlements
26th Oct 20219:00 amRNSFinalisation: Unbundling by OMU of portion of NED
22nd Sep 20212:01 pmRNSNew financial instrument listing
7th Sep 20218:30 amRNSOML Dividend Currency Equivalents
31st Aug 20214:30 pmRNSInvitation to shareholders
31st Aug 20214:30 pmRNSDirectorate Change
31st Aug 20217:00 amRNSInterim Results and Trading Statement
18th Aug 20217:00 amRNSTrading Statement
26th Jul 202111:30 amRNSAcquisition of securities
23rd Jun 20214:45 pmRNSUnbundling of a portion of shareholding in NGL
23rd Jun 20217:00 amRNSVoluntary Operating Update
21st May 20213:15 pmRNSResult of AGM
21st May 20217:00 amRNSVoluntary Operating Update
4th May 20219:46 amRNSChange of Auditor
4th May 20219:46 amRNSAppointment of Lead Independent Director
19th Apr 20214:30 pmRNSAGM Statement
19th Apr 20211:45 pmRNSDirector/PDMR Shareholding
14th Apr 20214:00 pmRNSDirector/PDMR Shareholding
13th Apr 20211:50 pmRNSCorrection: Director/PDMR Shareholding
13th Apr 20211:00 pmRNSDirector/PDMR Shareholding
12th Apr 20214:45 pmRNSDealings in securities on behalf of ESIS
8th Apr 20214:30 pmRNSDealings in securities on behalf of ESIS
29th Mar 20219:30 amRNSDividend Currency Equivalents
23rd Mar 20217:00 amRNSAnnual Results for the year ended 31 December 2020
8th Mar 20217:00 amRNSTrading Statement
25th Jan 20217:00 amRNSPreliminary Operating Update
14th Dec 202011:30 amRNSChange in Directorate
3rd Nov 20207:00 amRNSDirectorate Change
16th Sep 20204:15 pmRNSDealings in securities on behalf of BBBEEE Trust
1st Sep 20207:00 amRNSInterim Results for the six months ended 30 June
24th Aug 20207:00 amRNSTrading Statement
29th Jul 20203:45 pmRNSOld Mutual Insure - business interruption
7th Jul 20208:00 amRNSInvestor Conference Call
3rd Jul 202012:40 pmRNSAppointment of Chief Executive Officer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.